If you put aside the “breakthroughs”, “remarkables” and heralding new eras, the key is the statement that this all needs confirming by a randomised controlled trial with placebo which I suppose means Lu plus Nox drug vs Lu plus placebo.
In other words this ain’t coming to a regulatory agency any time soon.
The wide confidence interval for survival 9-30 months shows how imprecise the reported survival estimate is. No problems with that, just all down to being small trial. promising at best, But you don’t usually herald a new era with something like this.
- Forums
- ASX - By Stock
- NOX
- Ann: LuPIN Survival Outcome Confirmed by Conference Presentation
Ann: LuPIN Survival Outcome Confirmed by Conference Presentation, page-7
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
-0.002(2.94%) |
Mkt cap ! $20.16M |
Open | High | Low | Value | Volume |
6.7¢ | 6.9¢ | 6.6¢ | $13.31K | 198.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1137 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 22400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1137 | 0.066 |
1 | 100000 | 0.064 |
3 | 47786 | 0.061 |
4 | 105033 | 0.060 |
2 | 120000 | 0.059 |
Price($) | Vol. | No. |
---|---|---|
0.067 | 22400 | 1 |
0.068 | 10783 | 1 |
0.069 | 10640 | 1 |
0.079 | 12000 | 2 |
0.080 | 12099 | 2 |
Last trade - 15.50pm 28/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online